Defining early-onset kidney cancer: Implications for germline and somatic mutation testing and clinical management

140Citations
Citations of this article
178Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Approximately 5% to 8% of renal cell carcinoma (RCC) is hereditary. No guidelines exist for patient selection for RCC germline mutation testing. We evaluate how age of onset could indicate the need for germline mutation testing for detection of inherited forms of kidney cancer. Patients and Methods: We analyzed the age distribution of RCC cases in the SEER-17 program and in our institutional hereditary kidney cancer population. The age distributions were compared by sex, race, histology, and hereditary cancer syndrome. Models were established to evaluate the specific age thresholds for genetic testing. Results: The median age of patients with RCC in SEER-17 was 64 years, with the distribution closely approaching normalcy. Statistical differences were observed by race, sex, and subtype (P

Cite

CITATION STYLE

APA

Shuch, B., Vourganti, S., Ricketts, C. J., Middleton, L., Peterson, J., Merino, M. J., … Linehan, W. M. (2014). Defining early-onset kidney cancer: Implications for germline and somatic mutation testing and clinical management. Journal of Clinical Oncology, 32(5), 431–437. https://doi.org/10.1200/JCO.2013.50.8192

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free